| The Role of Cognitive Control in the Transdiagnostic Conceptualization of "Intrusive Thoughts" (NCT03414619) | Massachusetts General Hospital | 2018-05-18 |
| Concurrent fMRI-guided rTMS and Cognitive Therapy for the Treatment of Major Depressive Episodes (NCT03289923) | National Institute of Mental Health (NIMH) | 2018-05-17 |
| Individualizing Incentives for Alcohol in the Severely Mentally Ill (NCT03481049) | Washington State University | 2018-05-05 |
| Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder (NCT03537547) | Washington University School of Medicine | 2018-05-04 |
| rTMS for MDD: 5.5cm Rule vs. F3 Targeting (NCT03378570) | Nicholas Trapp | 2018-05-01 |
| Pharmacogenomic Testing to Optimize Antidepressant Drug Therapy (NCT03591224) | John Papastergiou Pharmacy Ltd | 2018-04-17 |
| Switching From SSRI to Desvenlafaxine on Cognitive Functioning (NCT03432221) | Corporacion Parc Tauli | 2018-04-03 |
| A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disorder (NCT03446846) | Minerva Neurosciences | 2018-03-30 |
| Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volunteers (NCT03504475) | Beijing Tongren Hospital | 2018-03-29 |
| tDCS as add-on Treatment to Cognitive-Behavior Therapy in People With MDD (NCT03548545) | University of Minho | 2018-03-28 |
| Pathophysiology of Neurodegeneration in Late-life Depression (AV45+THK) (NCT03430869) | Chang Gung Memorial Hospital | 2018-03-23 |
| Allogeneic Human Mesenchymal Stem Cell Infusion vs Placebo in Alcohol Use Disorder and Major Depression. (NCT03265808) | Ihsan M Salloum, MD, MPH | 2018-03-18 |
| Transdiagnostic Markers of Cognitive Symptoms in Disorders Affective. (NCT05523076) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2018-03-15 |
| Integral Remediation for Major Depression ("Rehabilitación Integral Para la Depresión Mayor", RIDEM) (NCT03624621) | Hospital de Sant Pau | 2018-03-15 |
| Sleep To Reduce Incident Depression Effectively (NCT03322774) | Henry Ford Health System | 2018-03-09 |
| Neuro-Cardiac-Guided Transcranial Magnetic Stimulation: Replication and Dose-response. (NCT03652597) | Utrecht University | 2018-03-06 |
| AV-101 as Adjunct Antidepressant Therapy in Patients With Major Depression (NCT03078322) | VistaGen Therapeutics, Inc. | 2018-03-05 |
| tDCS Intervention on Motivational Anhedonia of Major Depressive Disorder (NCT04425278) | Anhui Medical University | 2018-03-01 |
| Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder (NCT03554174) | Yale University | 2018-02-27 |
| Transcranial Direct Current Stimulation in Major Depression (NCT03556124) | University of California, Los Angeles | 2018-02-02 |
| Trial of MR-guided Focused Ultrasound for Treatment of Refractory Major Depression (NCT03421574) | Sunnybrook Health Sciences Centre | 2018-01-19 |
| Citalopram Titration in Early Non-responder Patients With Major Depressive Disorders (NCT03899285) | Ciusss de L'Est de l'Île de Montréal | 2018-01-08 |
| Controlled Study to Evaluate the Safety and Efficacy of the Predictix Antidepressant Clinician Support Tool (NCT04031157) | Taliaz Ltd. | 2018-01-01 |
| Trial of Surf and Hike Therapy for Major Depressive Disorder (NCT03302611) | United States Naval Medical Center, San Diego | 2018-01-01 |
| Intermittent Theta Burst Stimulation for MDD (NCT02506127) | University of California, Los Angeles | 2017-12-09 |
| Software Treatments for Actively Reducing Severity of Cognitive Deficits in MDD (STARS-MDD) (NCT03310281) | Akili Interactive Labs, Inc. | 2017-12-04 |
| Adaptive Design Study of NEST sTMS in Subjects With Major Depressive Disorder (NCT03288714) | Wave Neuroscience | 2017-11-27 |
| Relative Bioavailability (RBA) Study of LY03005 vs Pristiq® (NCT03357796) | Luye Pharma Group Ltd. | 2017-11-27 |
| Real-life Effectiveness of Vortioxetine in Depression (NCT03555136) | H. Lundbeck A/S | 2017-11-17 |
| Effect of Self-administered tDCS in Patients With MDD (NCT04543123) | Jeong-Ho Chae | 2017-11-16 |
| Effects of Cannabis Abstinence on Symptoms and Cognition in Depression (NCT03624933) | Centre for Addiction and Mental Health | 2017-11-06 |
| Investigation of Seasonal Variations of Brain Structure and Connectivity in SAD (NCT03313674) | Sunnybrook Health Sciences Centre | 2017-11-01 |
| Targeting Cognitive Immunization in Depression (NCT03460574) | Philipps University Marburg | 2017-10-14 |
| Cognitive Behavioural Therapy for the Treatment of Late Life Depression (NCT03735576) | University of Cologne | 2017-10-01 |
| A Study of Pregnant and Postpartum Women With and Without Mood Disorders (NCT03615794) | Johns Hopkins University | 2017-10-01 |
| Effectiveness of a Mobile Texting Intervention for People With Serious Mental Illness (NCT03062267) | University of Washington | 2017-10-01 |
| Sex, Hormones and Gamma-Aminobutyric Acid (GABA) in Stress Induced Anhedonia in Depression (NCT03031665) | Mclean Hospital | 2017-10-01 |
| Adapted Cognitive Behavioral Treatment for Depression in Patients With Moderate to Severe Traumatic Brain Injury (NCT03307070) | Massachusetts General Hospital | 2017-09-23 |
| McLean and Genomind Prospective Study (NCT03113890) | Mclean Hospital | 2017-09-22 |
| Effects of Schema Therapy vs. Cognitive Behavioral Therapy vs. Individual Supportive Therapy (NCT03287362) | Max-Planck-Institute of Psychiatry | 2017-09-13 |
| Lipopolysaccharide (LPS) Challenge in Depression (NCT03142919) | Laureate Institute for Brain Research, Inc. | 2017-09-07 |
| Identification of Physiological Data by a Wearable Monitor in Subjects Suffering From Major Depression Disorders (NCT05547035) | Digital For Mental Health | 2017-09-05 |
| Multimodal Imaging of ECT Effects (NCT02871141) | Charite University, Berlin, Germany | 2017-09-01 |
| Treatment of Depression With Connectivity Guided Robotically Delivered rTMS (NCT02802293) | The University of Texas Health Science Center at San Antonio | 2017-08-17 |
| Effects of Psilocybin in Major Depressive Disorder (NCT03181529) | Johns Hopkins University | 2017-08-10 |
| Testing the Value of Smartphone Assessments of People With Mood Disorders (NCT03429361) | Mindstrong | 2017-08-08 |
| Creatine for Treatment of Depression Associated With Type 2 Diabetes (NCT03202095) | University of Utah | 2017-08-01 |
| Pharmacogenomic Testing in Major Depressive Disorder (NCT03228953) | Columbia University | 2017-08-01 |
| Lactobacillus Plantarum PS128 in Patients With Major Depressive Disorder and High Level of Inflammation (NCT03237078) | Taipei Medical University WanFang Hospital | 2017-08-01 |
| Do Omega-3 Fatty Acids Have an Antidepressant Effect in Patients With Signs of Peripheral Inflammation? (NCT03143075) | Region Skane | 2017-08-01 |
| Eealy Improvement Predicts Antidepressants Response in Adults With Major Depression Disorder (NCT03230682) | Huashan Hospital | 2017-07-25 |
| Patient Management of Depression Through Technology: a Study of Digitally Enabled Engagement (NCT03242213) | Wake Forest University Health Sciences | 2017-07-20 |
| The Modular Protocol for Mental Health (MPMH) (NCT03143634) | Medical Research Council Cognition and Brain Sciences Unit | 2017-07-18 |
| Mini Theta Burst TMS in MDD Patients (NCT04014959) | University of Pennsylvania | 2017-07-14 |
| Transdiagnostic Brain-Behavior Profiling to Enhance Cognitive Behavioral Therapy Response (NCT03175068) | University of Illinois at Chicago | 2017-07-05 |
| A Study to Evaluate the Safety and Efficacy of TS-121 as an Adjunctive Treatment for Major Depressive Disorder (NCT03093025) | Taisho Pharmaceutical R&D Inc. | 2017-07-03 |
| Lifestyle Intervention for Young Adults With Serious Mental Illness (NCT02815813) | Dartmouth-Hitchcock Medical Center | 2017-07-03 |
| Study of Naltrexone-Induced Blockade of Antidepressant Effects (NCT04322526) | Marta Peciña, MD PhD | 2017-07-01 |
| Simplified Cognitive Behavioral Therapy for Generalized Anxiety Disorder and Depression (NCT03329287) | Shanghai Mental Health Center | 2017-07-01 |
| Comparison of Anyu Peibo With Placebo in Treatment of MDD，Ⅱb (NCT03183505) | Shanghai Mental Health Center | 2017-06-30 |
| A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD) (NCT03188185) | Alkermes, Inc. | 2017-06-12 |
| BTRX-246040 Administered Once Daily to Patients With Major Depressive Disorder (NCT03193398) | BlackThorn Therapeutics, Inc. | 2017-06-12 |
| Novel Neural Circuit Biomarkers of Major Depression Response to CCBT (NCT03096886) | University of Pennsylvania | 2017-06-05 |
| Efficacy of Cranial Electrotherapy Stimulation (CES) for the Treatment of Major Depressive Disorder (NCT03222752) | Electromedical Products International, Inc. | 2017-06-05 |
| NMDA Modulation in Major Depressive Disorder (NCT04637620) | China Medical University Hospital | 2017-06-01 |
| Laughter Yoga Intervention for People With Major Depressive Disorder (NCT03163940) | The Hong Kong Polytechnic University | 2017-06-01 |
| Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder (NCT03065335) | National Institute of Mental Health (NIMH) | 2017-05-25 |
| Neural Mechanisms of Monoaminergic Engagement in Late-life Depression Treatment Response (NEMO) (NCT03128021) | Howard Aizenstein | 2017-05-24 |
| THINC-it Vortioxetine - Sensitivity to Change (NCT03053362) | Brain and Cognition Discovery Foundation | 2017-05-24 |
| Improving Access to the Treatment of Anxiety and Depression Among Young Adults (NCT03156556) | Universite de Moncton | 2017-05-15 |
| The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using Actigraphy (NCT02669082) | Takeda | 2017-05-09 |
| Rapid Antidepressant Effects of ATP and Phosphocreatine (NCT03138681) | Zhujiang Hospital | 2017-05-03 |
| Storytelling Video Intervention for Depressed Primary Care Patients - Pilot Trial (NCT02311725) | Butler Hospital | 2017-05-01 |
| Effects of Intravenous (IV) Citalopram Hydrochloride During Transcranial Magnetic Stimulation in Major Depressive Disorder (MDD) (NCT04846829) | University of California, Los Angeles | 2017-04-24 |
| Accelerated TMS to a Novel Brain Target in MDD and PTSD (NCT03114891) | University of Pennsylvania | 2017-04-20 |
| Escitalopram in the Treatment of Adolescents With Major Depressive Disorder or Anxiety Disorders (NCT03122158) | Erzurum Regional Training & Research Hospital | 2017-04-08 |
| ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD) (NCT03113968) | Bo Hu | 2017-04-07 |
| Effectiveness Study of Scopolamine Combined With Escitalopram in Patients With MDD (NCT03131050) | Capital Medical University | 2017-03-15 |
| Rapid Antidepressant Effects of Leucine (NCT03079297) | University of Texas Southwestern Medical Center | 2017-03-09 |
| Cognitive and Mood Assessment Data in Major Depressive Disorder Using Digital Wearable Technology (NCT03067506) | Takeda | 2017-03-01 |
| A Six Week, Randomized, Double-Blind Placebo-Controlled, Suvorexant Augmentation Study of Antidepressant Treatment of Major Depressive Disorder With Residual Insomnia (NCT02669030) | Institute for Advanced Medical Research, Alpharetta, GA | 2017-03-01 |
| The Experience of Older Adults Facing Depression for the First Time in Old Age (NCT03009448) | Shalvata Mental Health Center | 2017-03-01 |
| Optimizing Outcomes of Treatment-Resistant Depression in Older Adults (NCT02960763) | Washington University School of Medicine | 2017-02-24 |
| Hyperthermic Yoga for Depressive Symptoms (NCT02607514) | Massachusetts General Hospital | 2017-02-20 |
| Open Label Ketamine Treatment for Major Depressive Disorder in Veterans (NCT03053830) | VA Connecticut Healthcare System | 2017-01-31 |
| Levomilnacipran ER vs. Adjunctive Quetiapine for Adults With Inadequate Relief With SSRIs in MDD (NCT02720198) | Duke University | 2017-01-23 |
| Imaging mGluR5 and Synaptic Density in Psychiatric Disorders (NCT03898297) | Yale University | 2017-01-11 |
| Combined Sertraline and Ketoprofen Administration in Major Depressive Disorder (NCT03514810) | Kufa University | 2017-01-10 |
| The Treatment of Depression With Yoga and Walking (NCT02907476) | Boston University | 2017-01-04 |
| The Antidiabetic Metformin as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients (NCT04088448) | Sadat City University | 2017-01-01 |
| Pain, Reward, Attention and Neurocircuitry: Biomarkers of Suicidality (NCT02811198) | Unity Health Toronto | 2017-01-01 |
| Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive Disorder (NCT02972632) | Takeda | 2016-12-22 |
| The Study of Effectiveness of rTMS on Rumination and Anhedonia in Patients With Major Depressive Disorder (NCT03468686) | University of Tehran | 2016-12-21 |
| Yoga for Young Women With Depression (NCT03388177) | University of Groningen | 2016-12-16 |
| Safety and Tolerability of Zelquistinel in Normal Human Volunteers (NCT04981561) | Syndeio Biosciences, Inc | 2016-12-09 |
| The Relationship Among Changes in Brain Network Activation in Adult Outpatients With Major Depressive Disorder (NCT02749721) | Rush University Medical Center | 2016-12-01 |
| Examining the Effects of Reduced Environmental Stimulation on Anxiety (NCT03051074) | Laureate Institute for Brain Research, Inc. | 2016-12-01 |
| The UTHealth Ketamine Project (NCT02882711) | The University of Texas Health Science Center, Houston | 2016-11-07 |
| Placebo-controlled Trial of 5-hydroxytryptophan and Creatine for SSRI or SNRI Augmentation in Treatment Resistant Depression in Females (NCT02922725) | Brent Michael Kious, MD, PhD | 2016-11-01 |
| Augmentation of Treatment-Resistant Depression With An Analog of the Neuroactive Steroid Allopregnanolone (NCT02900092) | Massachusetts General Hospital | 2016-11-01 |